Prostate Cancer Trial, Recruiting NCT06325774 Sponsor: Changhai Hospital Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06325774
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People whose general health and ability to carry out daily activities meets a certain minimum level, based on a standard medical scoring system called the ECOG scale (score of 2 or lower, meaning able to carry out basic self-care)
  • People who have been confirmed through laboratory testing (pathology) to have prostate cancer
  • People whose cancer has not spread to nearby lymph nodes or other parts of the body (based on clinical staging)
  • People whose life expectancy is estimated to be more than 5 years
  • People who have no medical reasons preventing them from having radiation therapy, and who are willing to receive it
  • People who have been informed about other available treatment options and have chosen to voluntarily take part in this study

Who may not be able to join:

  • People who have already received any treatment for prostate cancer, including radiation, chemotherapy, or focused/localised treatments
  • People who have previously had radiation therapy to the pelvis or abdomen
  • People who have previously received hormone therapy for prostate cancer (such as castration or anti-androgen medications)
  • People who have another type of cancer, or who have certain infections including HIV, Hepatitis C, or syphilis
  • People who have other serious ongoing health conditions affecting the respiratory, circulatory, nervous, mental, digestive, hormonal, immune, or urinary systems that the trial doctors consider would make participation unsuitable
  • People who have medical reasons that make radiation therapy unsafe for them
  • People who are currently taking part in another clinical trial that conflicts with this one, or who have done so within the 4 weeks before this study begins
  • People who are unable to provide written consent to participate, or who are unlikely to follow the study requirements consistently

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 021-31162222

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Changhai Hospital
Registry
ClinicalTrials.gov
Start date
1 September 2024
Est. completion
1 September 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of radiotherapy-related gastrointestinal and urogenital tract adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov